Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.

@article{Yamazaki2012SubfovealCT,
  title={Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.},
  author={Taizo Yamazaki and Hideki Koizumi and Tetsuya Yamagishi and Shigeru Kinoshita},
  journal={Ophthalmology},
  year={2012},
  volume={119 8},
  pages={1621-7}
}
PURPOSE To investigate the changes in subfoveal choroidal thickness after intravitreal injections of ranibizumab (IVRs) for neovascular age-related macular degeneration (AMD). DESIGN Prospective, consecutive, interventional case series. PARTICIPANTS Eighty eyes (40 affected eyes with neovascular AMD and 40 unaffected fellow eyes) of 40 patients. METHODS Forty eyes with neovascular AMD were treated with 0.5-mg IVRs monthly for 3 months and received additional IVRs as needed over the… CONTINUE READING
54 Citations
45 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Similar Papers

Loading similar papers…